Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Geography And History Shape Genetic Differences In Humans
New research indicates that natural selection may shape the human genome
generic viagra online
Shutting Down Health Care Fraud; Increasing Transparency
U.S. Senator Mel Martinez (R-FL) joined with U.S. Senator Amy Klobuchar (D-MN) on an effort to require all Medicare and Medicaid provider payments to be made through direct deposit at federally-insured banking institutions. If signed into law, this measure will make it easier to track providers engaged in fraud thereby dramatically reducing the estimated loss of more than $60 billion every year.
News of the day
ImClone Systems And Bristol-Myers Squibb Announce Revisions To ERBITUX(R) (cetuximab) U.S. Product Labeling For Metastatic Colorectal Cancer
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY), and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved revisions to the U.S. prescribing information for ERBITUX® (cetuximab) concerning the treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer (mCRC). The labeling revisions include a modification to the indication, which now includes a statement that retrospective subset analyses of metastatic or advanced colorectal cancer trials have not shown a treatment benefit for ERBITUX in patients whose tumors had K-ras mutations in codon 12 or 13 and that the use of ERBITUX is not recommended for the treatment of colorectal cancer with these mutations. Revisions concerning the use of ERBITUX in colorectal cancer tumors with K-ras mutations were also made to the clinical studies and clinical pharmacology sections of the product"s prescribing information.
Medical Devices

Franken To Be Seated As Minn. Senator, Will Serve On HELP, Judiciary Committees

The Minnesota Supreme Court on Tuesday unanimously voted to uphold Al Franken"s (D) win in the 2008 U.S. Senate election in Minnesota, effectively clearing the way for Franken to become the state"s newest senator, the Wall Street Journal reports. His election gives Democrats in the Senate a 60-vote supermajority, which could help the party pass health care reform legislation, according to the Journal. Following the ruling, opponent Sen. Norm Coleman (R-Minn.) conceded the election, and Minnesota Gov. Tim Pawlenty (R) said that he would certify the result Tuesday.Franken is expected to be seated next week. He will join the Senate Judiciary Committee, where he will vote on the Supreme Court nomination of Judge Sonia Sotomayor, and the Senate Health, Education, Labor and Pensions Committee, which is completing its draft of health care reform legislation (Bendavid/Hitt, Wall Street Journal, 7/1). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009